Orange CA 多发性骨髓瘤临床试验
9项针对 多发性骨髓瘤的研究正在 Orange及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
招募中3 期
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
招募中3 期
- Research Site, Orange
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- UC Irvine, Orange
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
招募中3 期
- Chao Family Comprehensive Cancer Center UCI, Orange
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- University of California Irvine Medical Center, Orange
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- UC Irvine Health, Orange
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
招募中3 期
- Research Site, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
招募中2 期
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
招募中4 期
- UC Irvine Health, Orange
- UCI Health, Orange
其他城市的 多发性骨髓瘤试验
- New York City, NY59 项研究
- Boston, MA45 项研究
- Atlanta, GA42 项研究
- Houston, TX39 项研究
- Durham, NC36 项研究
- Nashville, TN31 项研究
- Denver, CO26 项研究
- St. Louis, MO26 项研究
- Rochester, MN25 项研究
- Columbus, OH25 项研究
- Chicago, IL24 项研究
- Milwaukee, WI23 项研究
Orange的其他研究
- 非小细胞肺癌28 项研究
- 转移性癌症21 项研究
- 卵巢癌16 项研究
- 结直肠癌16 项研究
- 癌症（所有类型）15 项研究
- 胰腺癌15 项研究
- 肺癌15 项研究
- 肝癌（肝细胞癌）14 项研究
- 黑色素瘤14 项研究
- 重度抑郁症13 项研究
- 胃癌13 项研究
- 前列腺癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。